3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
19
Ovarian Neoplasms
11
Neoplasms
7
Liposarcoma
7
Leiomyosarcoma
7
Neoplasm Metastasis
4
Sarcoma, Ewing
3
Breast Neoplasms
3
Solitary Fibrous Tumors
2
Sarcoma, Synovial
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Liposarcoma, Myxoid
2
Histiocytoma, Malignant Fibrous
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Wilms Tumor
1
Uterine Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Soft Tissue Neoplasms
1
Skin Diseases
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Recurrent High Grade Meningioma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Diseases
1
Interventions
Ibandronic Acid
5
Zoledronic Acid
3
Denosumab
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Injections
2
Curettage
2
selinexor
1
saracatinib
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
olaparib
1
montanide ISA 51
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
endostar protein
1
cc-486
1
angiotensin I (1-7)
1
Vincristine
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Transcranial Direct Current Stimulation
1
Trabectedin
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Neoplasms
×
Trabectedin
×
Clear all
NCT02398058
2021-04-14
TOMAS
Italian Sarcoma Group
Phase 1
Completed
50 enrolled